Richard Kozakiewicz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 418 W Monroe Ave, Chester, MT 59522 Phone: 406-759-5194 |
News Archive
Celldex Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. Celldex reported a net loss of $13.5 million, or $0.43 per share, for the fourth quarter of 2009 compared to a net loss of $7.5 million, or $0.47 per share, for the fourth quarter of 2008.
In its budget and economic outlook, the Congressional Budget Office projects an 8 percent annual increase in health spending between 2012 and 2022, mainly because of an aging U.S. population and rising treatment costs. The analysis includes a bigger pricetag for a permanent fix to the Medicare physician payment formula.
A group led by Starr Investment Holdings said Monday that it is buying MultiPlan Inc., which helps manage claims for large health insurers. The price was $4.4 billion, according to a person close to the deal, who spoke on condition of anonymity because the companies did not disclose terms (2/17).
An innovative robotic sample management system developed by the SME-led PMS project carries out complex sample transport operations rapidly and with a high level of reliability. It includes a new transport system based on magnetic hover railway technologies, a new laboratory information system and a special selective analyser. PMS partners are now predicting a substantial market share for their transport system.
1st International Symposium on Deuterium Depletion was held on 13-14 May 2010 in Budapest, Hungary. The conference programme focused on the advances in the research and clinical application of deuterium depletion, its present and future role in anticancer research and oncotherapy, diabetes research and anti-aging.
› Verified 1 days ago